James Samuel Shannon - Net Worth and Insider Trading
James Samuel Shannon Net Worth
The estimated net worth of James Samuel Shannon is at least $4 Million dollars as of 2024-09-20. James Samuel Shannon is the Director of Horizon Therapeutics PLC and owns about 33,604 shares of Horizon Therapeutics PLC (HZNP) stock worth over $4 Million. Details can be seen in James Samuel Shannon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Samuel Shannon has not made any transactions after 2021-03-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James Samuel Shannon
James Samuel Shannon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Samuel Shannon owns 3 companies in total, including Horizon Therapeutics PLC (HZNP) , MannKind Corp (MNKD) , and Endocyte Inc (ECYT) .
Click here to see the complete history of James Samuel Shannon’s form 4 insider trades.
Insider Ownership Summary of James Samuel Shannon
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HZNP | Horizon Therapeutics PLC | 2021-03-01 | director |
MNKD | MannKind Corp | 2010-02-24 | director |
ECYT | Endocyte Inc | 2011-05-26 | director |
James Samuel Shannon Latest Holdings Summary
James Samuel Shannon currently owns a total of 1 stock. James Samuel Shannon owns 33,604 shares of Horizon Therapeutics PLC (HZNP) as of March 1, 2021, with a value of $4 Million.
Latest Holdings of James Samuel Shannon
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HZNP | Horizon Therapeutics PLC | 2021-03-01 | 33,604 | 116.30 | 3,908,145 |
Holding Weightings of James Samuel Shannon
James Samuel Shannon Form 4 Trading Tracker
According to the SEC Form 4 filings, James Samuel Shannon has made a total of 1 transactions in Horizon Therapeutics PLC (HZNP) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Horizon Therapeutics PLC is the sale of 7,232 shares on March 1, 2021, which brought James Samuel Shannon around $660,282.
Insider Trading History of James Samuel Shannon
- 1
James Samuel Shannon Trading Performance
James Samuel Shannon Ownership Network
James Samuel Shannon Owned Company Details
What does Horizon Therapeutics PLC do?
Who are the key executives at Horizon Therapeutics PLC?
James Samuel Shannon is the director of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include EVP and Chief Business Officer Andy Pasternak , EVP & Chief Financial Officer Aaron Cox , and EVP & Chief Medical Officer Jeffrey W Sherman .
Horizon Therapeutics PLC (HZNP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Horizon Therapeutics PLC (HZNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Horizon Therapeutics PLC Insider Transactions
James Samuel Shannon Mailing Address
Above is the net worth, insider trading, and ownership report for James Samuel Shannon. You might contact James Samuel Shannon via mailing address: 28903 North Avenue Paine, Valencia Ca 91355.